Wednesday, May 29, 2019

Epigenetic study provides new approaches to combination therapies for aggressive cancers

A recent study reveals how the interaction of the epigenetic protein BRD4 with the metabolic enzyme MTHFD1 controls gene expression and cell proliferation. The results of the study have now been published in the renowned journal Nature Genetics. They suggest novel approaches for the development of combination therapies for aggressive cancers.

from Top Health News -- ScienceDaily http://bit.ly/2YOyvfA

No comments:

Post a Comment

Ebola and hantavirus can start like the flu but turn deadly fast

Two dangerous viruses are back in the spotlight, reminding health officials how quickly infectious diseases can become serious threats. Hant...